S&P 500   4,486.46
DOW   35,258.61
QQQ   372.65
S&P 500   4,486.46
DOW   35,258.61
QQQ   372.65
S&P 500   4,486.46
DOW   35,258.61
QQQ   372.65
S&P 500   4,486.46
DOW   35,258.61
QQQ   372.65

Avenue Therapeutics Short Interest Ratio and Short Volume

-0.01 (-0.79 %)
(As of 10/18/2021 12:00 AM ET)
Today's Range
50-Day Range
52-Week Range
Volume71,439 shs
Average Volume232,857 shs
Market Capitalization$21.16 million
P/E RatioN/A
Dividend YieldN/A

Avenue Therapeutics (NASDAQ:ATXI) Short Interest Data

Current Short Volume250,200 shares
Previous Short Volume278,400 shares
Change Vs. Previous Month-10.13%
Dollar Volume Sold Short$372,798.00
Short Interest Ratio / Days to Cover3.0
Last Record DateSeptember, 30 2021
Outstanding Shares16,793,000 shares
Float Size6,620,000 shares
Short Percent of Float3.78%
Today's Trading Volume71,439 shares
Average Trading Volume232,857 shares
Today's Volume Vs. Average-69.32%

Days to Cover Over Time

Percentage of Float Shorted Over Time

cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook
Short Selling Avenue Therapeutics ?

Sign up to receive the latest short interest report for Avenue Therapeutics and its competitors with MarketBeat's FREE newsletter.

Avenue Therapeutics (NASDAQ:ATXI) Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
9/30/2021250,200 shares $372,798.00 -10.1%3.8%3 $1.49
9/15/2021278,400 shares $462,144.00 -1.7%4.2%2 $1.66
8/31/2021283,300 shares $512,773.00 +6.7%4.3%1 $1.81
8/13/2021265,400 shares $453,834.00 -13.8%4.0%0.9 $1.71
7/30/2021308,000 shares $551,320.00 -27.0%4.7%1 $1.79
7/15/2021421,800 shares $873,126.00 +17.8%6.4%1.3 $2.07
6/30/2021358,100 shares $898,831.00 -28.0%5.4%0.9 $2.51
6/15/2021497,000 shares $1.39 million -4.5%7.5%1.2 $2.80
5/28/2021520,500 shares $2.58 million -2.3%7.9%1.8 $4.96
5/14/2021532,500 shares $2.22 million -13.8%8.0%1.6 $4.16
4/30/2021617,400 shares $3.24 million 0.0%9.3%1.8 $5.24
4/15/2021617,500 shares $2.95 million +37.6%9.3%2 $4.77
3/31/2021448,700 shares $2.58 million +11.5%6.8%1.8 $5.75
3/15/2021402,500 shares $2.75 million +12.8%6.1%1.5 $6.84
2/26/2021357,000 shares $1.76 million -6.9%5.4%0.9 $4.94
2/12/2021383,600 shares $2.62 million -17.9%5.8%1 $6.83
1/29/2021467,000 shares $2.81 million -11.2%7.0%1.2 $6.01
1/15/2021526,000 shares $3.31 million -12.4%7.9%1.4 $6.30
12/31/2020600,600 shares $3.48 million +73.7%9.0%1.1 $5.80
12/15/2020345,800 shares $1.25 million +13.0%5.2%0.6 $3.62
11/30/2020306,100 shares $1.04 million -7.2%4.6%1 $3.41
11/15/2020329,900 shares $1.09 million +9.8%5.0%1.2 $3.29
10/30/2020300,500 shares $955,590.00 +4.1%4.5%1.1 $3.18
10/15/2020288,800 shares $1.15 million +110.7%4.4%1.2 $3.98
9/30/2020137,100 shares $1.48 million -8.1%2.1%3 $10.83

Avenue Therapeutics (NASDAQ:ATXI) Short Interest FAQ

Avenue Therapeutics (NASDAQ:ATXI) Short Interest Frequently Asked Questions

What is Avenue Therapeutics' current short interest?

Short interest is the volume of Avenue Therapeutics shares that have been sold short but have not yet been closed out or covered. As of September 30th, investors have sold 250,200 shares of ATXI short. 3.78% of Avenue Therapeutics' shares are currently sold short. Learn More on Avenue Therapeutics' current short interest.

What is a good short interest ratio for Avenue Therapeutics?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. Avenue Therapeutics currently has a short interest ratio of 3.0. Learn More on a good short interest ratio for Avenue Therapeutics

What is a good short interest percentage for Avenue Therapeutics?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 3.78% of Avenue Therapeutics' floating shares are currently sold short.

Is Avenue Therapeutics' short interest increasing or decreasing?

Avenue Therapeutics saw a decline in short interest during the month of September. As of September 30th, there was short interest totaling 250,200 shares, a decline of 10.1% from the previous total of 278,400 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

What is Avenue Therapeutics' float size?

Avenue Therapeutics currently has issued a total of 16,793,000 shares. Some of Avenue Therapeutics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Avenue Therapeutics currently has a public float of 6,620,000 shares.

How does Avenue Therapeutics' short interest compare to its competitors?

3.78% of Avenue Therapeutics' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Avenue Therapeutics: Biophytis SA (0.00%), Agile Therapeutics, Inc. (2.96%), Gain Therapeutics, Inc. (0.32%), Akari Therapeutics, Plc (0.00%), Stealth BioTherapeutics Corp (0.00%), DiaMedica Therapeutics Inc. (0.00%), Eledon Pharmaceuticals, Inc. (1.77%), Aravive, Inc. (3.48%), Adial Pharmaceuticals, Inc. (5.77%), and Lumos Pharma, Inc. (1.75%).

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: S&P Global Inc. ($7.35 billion), Advanced Micro Devices, Inc. ($6.43 billion), Charter Communications, Inc. ($5.68 billion), Wayfair Inc. ($4.48 billion), Uber Technologies, Inc. ($3.77 billion), Canadian Pacific Railway Limited ($3.73 billion), Palo Alto Networks, Inc. ($3.10 billion), Zoom Video Communications, Inc. ($2.87 billion), Match Group, Inc. ($2.83 billion), and DoorDash, Inc. ($2.54 billion). View all of the most shorted stocks.

What does it mean to sell short Avenue Therapeutics stock?

Short selling ATXI is an investing strategy that aims to generate trading profit from Avenue Therapeutics as its price is falling. Avenue Therapeutics' stock is trading down $0.01 today. To short Avenue Therapeutics stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that Avenue Therapeutics will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Avenue Therapeutics?

A short squeeze for Avenue Therapeutics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of ATXI, which in turn drives the price of the stock up even further.

How often is Avenue Therapeutics' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ATXI, twice per month. The most recent reporting period available is September, 30 2021.

This page was last updated on 10/19/2021 by MarketBeat.com Staff


Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.